z-logo
open-access-imgOpen Access
A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
Author(s) -
Julian Kaboggoza,
Xinxhu Wang,
Megan Neary,
Pedro Ayuso,
Christine SekaggyaWiltshire,
Shadia Nakalema,
Andrew Owen,
Myra O. McClure,
Mohammed Lamorde,
Marta Boffito
Publication year - 2019
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofz035
Subject(s) - medicine , isoniazid , efavirenz , rifampicin , tuberculosis , pharmacology , rifapentine , mycobacterium tuberculosis , virology , human immunodeficiency virus (hiv) , viral load , pathology , antiretroviral therapy , latent tuberculosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom